Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brain Armor is a health and wellness company specializing in cognitive health through evidence-based nutritional supplements. The company develops and markets plant-based Omega-3 formulations, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) derived from algal oil, to support brain structure and performance. Their products are designed for a wide range of users, including elite athletes, military personnel, and aging adults, with a focus on improving focus, memory, and resilience against head impacts. Brain Armor's "brain-first" approach emphasizes the importance of essential fatty acids in maintaining long-term neurological health. The company's formulations are often NSF Certified for Sport, making them a preferred choice for professional and collegiate athletic programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brain Armor.